Editorial review
Educational content is reviewed for source quality, clinical boundaries, and readability. It is not medical advice; confirm care decisions with a licensed clinician.
Frequently Asked Questions
Ketamine Tablets vs Troches
Tablets and troches are the two most commonly prescribed oral ketamine formulations. Despite both being taken by mouth, they work differently and produce meaningfully different pharmacokinetic profiles. Understanding these differences helps patients and prescribers select the formulation best suited to individual needs.
What Is the Actual Difference?
Ketamine tablets are solid dosage forms designed to be swallowed whole. The tablet passes through the stomach and small intestine, where ketamine is absorbed into the portal circulation and travels through the liver before reaching the systemic bloodstream. This first-pass hepatic metabolism converts 75-90% of the ketamine to norketamine and other metabolites.
Ketamine troches (also called lozenges or buccal tablets) are designed to dissolve slowly in the mouth over 15-30 minutes. Ketamine is absorbed through the buccal mucosa — the lining of the cheeks and under the tongue — partially bypassing the liver. Some of the dissolved troche is inevitably swallowed, so troches produce a combination of buccal and gastrointestinal absorption. See how to take ketamine tablets for practical administration guidance on both forms.
Head-to-Head Comparison
Bioavailability
| Tablets | Troches | |
|---|---|---|
| Bioavailability | 10-25% | 25-35% |
| Primary absorption route | GI tract | Buccal mucosa + GI tract |
| First-pass metabolism | Full | Partial bypass |
| Norketamine production | Higher relative to parent drug | Lower relative to parent drug |
The higher bioavailability of troches means that a lower milligram dose can achieve comparable plasma levels. A patient taking 200 mg via troche may achieve similar ketamine blood levels to a patient taking 300-400 mg via swallowed tablet.
Onset and Duration
Tablets: Onset in 30-60 minutes. Peak plasma levels at 1-2 hours. Effects lasting 3-5 hours total.
Troches: Onset in 15-30 minutes (buccal absorption begins while the troche is still dissolving). Peak plasma levels at 30-90 minutes. Effects lasting 3-4 hours total.
Troches generally produce a faster onset because buccal absorption delivers ketamine to the bloodstream without waiting for gastrointestinal transit and hepatic processing.
Administration
Tablets: Simple — swallow with water. No special technique required. Takes seconds.
Troches: Must be held in the mouth and allowed to dissolve over 15-30 minutes. Patients are often instructed to move the troche around the mouth to maximize mucosal contact. Some protocols advise holding saliva in the mouth rather than swallowing to maximize buccal absorption. The process requires patience and compliance.
Taste
This is a significant practical differentiator. Ketamine has a distinctly bitter, chemical taste that many patients find unpleasant.
Tablets: Minimal taste — the tablet is swallowed quickly and the taste exposure is brief.
Troches: Extended taste exposure for 15-30 minutes as the troche dissolves. Compounding pharmacies add flavoring (mint, citrus, berry), but the bitter ketamine taste is difficult to fully mask. Some patients find the taste intolerable and cannot comply with the full dissolution time.
Dosing Accuracy
Tablets: Highly consistent — each tablet contains a precise amount of drug. Dosing variability between tablets is minimal.
Troches: More variable in practice because absorption depends on how long the troche is held in the mouth, how much saliva is swallowed vs. retained, and the condition of the buccal mucosa. Two patients taking identical troches may absorb meaningfully different amounts.
Nausea
Tablets: Nausea is common (20-40%) because the full dose passes through the GI tract.
Troches: Potentially less nausea because buccal absorption reduces the amount of ketamine reaching the stomach. However, patients who swallow a significant portion of the dissolved troche may still experience nausea.
When Tablets Are the Better Choice
- Patients who cannot tolerate the taste of troches
- Patients who want the simplest possible administration
- Patients who need the most consistent, predictable dosing
- Patients who are uncomfortable holding medication in their mouth for extended periods
- Situations where dose titration requires precise milligram accuracy
When Troches Are the Better Choice
- Patients who need higher bioavailability without increasing the milligram dose
- Patients who experience significant nausea with swallowed tablets
- Patients who want faster onset of effects
- Patients comfortable with the dissolution technique and tolerant of the taste
- Clinicians targeting a more IV-like pharmacokinetic profile (faster onset, higher peak)
Switching Between Formulations
Patients and prescribers sometimes switch formulations during treatment:
Tablet to troche: Reduce the milligram dose by approximately 30-40% to account for the higher bioavailability. Monitor response and adjust.
Troche to tablet: Increase the milligram dose by approximately 30-50%. Monitor for reduced efficacy or increased GI side effects.
These are approximate guidelines — individual variation means that dose adjustments when switching should be guided by clinical response rather than strict conversion ratios.
The Bottom Line
Neither formulation is objectively superior. Tablets are simpler and more consistent; troches offer better bioavailability and faster onset. Many clinicians start with tablets for their ease of use and switch to troches if bioavailability or nausea is a concern. The best formulation is the one the patient will use consistently and tolerate well.
References
- StatPearls: Ketamine — Comprehensive clinical reference on ketamine pharmacology, mechanisms of action, and therapeutic applications
- PubChem: Ketamine Compound Summary — NCBI chemical database entry with ketamine molecular data, pharmacokinetics, and bioactivity profiles
- MedlinePlus: Ketamine — National Library of Medicine consumer drug information on ketamine including uses, proper administration, and precautions
- NIMH: Depression — National Institute of Mental Health overview of depressive disorders, treatment-resistant forms, and emerging therapies
Quick Answer
Ketamine tablets are pressed oral solid dosage forms that are swallowed and absorbed through the gut, while troches are soft compounded lozenges dissolved sublingually or in the buccal pouch. Tablets typically deliver oral bioavailability in the 17-24% range; troches held sublingually deliver roughly 24-30%. Tablets win on dose precision and shelf stability; troches win on faster onset and reduced first-pass loss. Neither is appropriate for patients with uncontrolled hypertension, active psychosis, or pregnancy without specialist oversight.
Frequently Asked Questions
What is a ketamine troche?
A ketamine troche is a soft, compounded lozenge designed to dissolve slowly under the tongue or in the cheek pouch. Unlike a swallowed tablet, the troche delivers ketamine across the oral mucosa, partially bypassing first-pass liver metabolism. Compounding pharmacies typically prepare troches in 50-200 mg strengths, customized per prescription.
What is ketamine troche bioavailability vs tablet bioavailability?
Sublingual troches held for 10-15 minutes typically achieve 24-30% bioavailability. Pressed oral tablets that are swallowed achieve roughly 17-24% bioavailability because the drug passes through the gut and liver before reaching circulation. If a troche is swallowed instead of held sublingually, its bioavailability drops into the same 17-24% range as a tablet.
How does ketamine troche dosing compare to tablet dosing?
Clinicians commonly prescribe sublingual troches in the 50-150 mg per session range, with some treatment plans reaching 200 mg under supervision. Oral tablet protocols generally land in a similar 50-200 mg range to compensate for the slightly lower bioavailability. Exact dosing depends on weight, indication, prior exposure, and prescriber judgment — never self-titrate.
What effects can I expect from a ketamine troche compared to a tablet?
Sublingual troches typically produce onset within 15-30 minutes and a 45-90 minute experience window. Swallowed tablets have a slower 30-60 minute onset and a longer 60-120 minute window because gut absorption is delayed and metabolites contribute more to the effect profile. Both forms are contraindicated in patients with uncontrolled cardiovascular disease, active psychosis, or significant hepatic impairment.
Are ketamine squares the same as troches?
'Ketamine squares' is informal slang for square-shaped compounded troches or lozenges, not a separate dosage form. They follow the same sublingual pharmacokinetics as round troches.
Verdict
Ketamine tablets and troches are both oral formulations of the same drug, but they differ meaningfully in absorption route and bioavailability. Tablets are swallowed and subject to full first-pass metabolism (10-25% bioavailability), while troches dissolve in the mouth for partial buccal absorption (25-35% bioavailability). Tablets offer simpler administration and more consistent dosing, while troches provide higher bioavailability and faster onset. The best choice depends on individual tolerance, taste sensitivity, and clinical goals — many patients try both before settling on a preference.
Share
Related Reading
Contact Ketamine Tablet
Send corrections, provider questions, or advertising inquiries.